Additional studies employing conventional sequencing evaluated the concordance of the specific mutations on other genes participating in the oncogenic process of CMM, like CDKN2A, MITF, EGFR, CCND1, cMET, and cKIT and others, evidencing differences in genes selected during tumor progression (like CDKN2A, MITF, etc.)[11]. Here, CDKN2A is linked to neoplasm.